BISPECIFIC

Welcome to the Brand page for “BISPECIFIC”, which is offered here for Therapeutic pharmaceutical preparations for use in the treatment of aids, infectious diseases, cancer, autoimmune diseases, cardiovascular diseases and allergies;bi-specific;biochemicals, antibodies for in vitro or scientific research regarding aids, infectious diseases, cancer, autoimmune diseases, cardiovascular diseases, and allergies;.

Its status is currently believed to be active. Its class is unavailable. “BISPECIFIC” is believed to be currently owned by “Medarex, Inc.”